Optimi Health Enters Asian Market, Collaborates With PsiloThai on Psilocybin Research

MT Newswires07/23 23:00

Optimi Health Up 7.8% as After Health Canada Go-Ahead to Supply MDMA and Psilocybin to Patients in Australia

MT Newswires06/25 23:30

Optimi Health Up 12% After Reporting Drug Establishment License From Health Canada

MT Newswires06/04 02:07

Optimi Health to Be Sole Supplier of Psilocybin for ATMA Journey Centers Phase II Trial

MT Newswires05/22 21:41

Optimi Health Notes Lykos Therapeutics and FDA Priority Review of New Drug Application

MT Newswires02/12 21:00

Optimi Health Secures Amendment to Increase Quantities of MDMA, MDA, and 2C-B

MT Newswires01/19 20:56